CompletedNot Applicable

Efficacy of the Nanodropper Device on Pupillary Dilation

United States50 participantsStarted 2021-07-29

Plain-language summary

Prescription eye drop bottles elute drops that exceed the capacity of the human eye by five times. This study describes performing in clinic dilation using a novel solution for combating medical waste with Nanodropper, an eye drop bottle adapter that creates smaller eye drops.

Who can participate

Age range2 Years – 17 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Participants under the age of 18 years old Exclusion Criteria: * Participants 18 years and older * Pupillary or anterior segment abnormality * Participants with pre-existing health conditions that would prevent pupillary dilation.

What they're measuring

Spherical Equivalent

Timeframe: Before dilation and 30 minutes after dilation

Maximum Pupil Diameter

Timeframe: Before dilation and 30 minutes after dilation

Constriction Percentage

Timeframe: Before and 30 minutes after dilation

Trial details

NCT IDNCT05274321

SponsorUniversity of California, San Francisco

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-11-19

Results submitted2023-07-03

View on ClinicalTrials.gov More Dilation trials